Why Novocure Stock Briefly Fell Today
In response to the reported fourth-quarter and full-year results, shares of NovoCure (NASDAQ: NVCR), a high-growth medical device company that is focused on cancer, fell as much as 12% in early-morning trading on Thursday. The stock eventually recovered and was down about 2% as of 3:05 p.m. EST.
Investors got a sneak peek at the company's fourth-quarter results in mid-January, so Wall Street already had a good idea of what the company's numbers looked like.
Here are the rest of the details from the period:
Source Fool.com